Literature DB >> 26175953

FGFR2 gene polymorphisms are associated with breast cancer risk in the Han Chinese population.

Peng Xia1, Bin Li2, Tingting Geng3, Zhiping Deng4, Chengxue Dang4, Dongmin Chang4, Longli Kang5, Tianbo Jin6, Chao Chen7.   

Abstract

AIMS AND
BACKGROUND: Breast cancer is one of the most common neoplasms among women in many developing countries including China, and is the leading cause of female cancer-related deaths worldwide.
METHODS: In the current study, we analyzed the relationship between 14 tag single-nucleotide polymorphisms (tSNPs) and breast cancer risk in the Han Chinese population including 185 breast cancer patients and 199 healthy women controls on the different types of breast cancer and menopausal status.
RESULTS: Overall, we found rs2981579 in the FGFR2 gene, and rs2380205 were associated with breast cancer susceptibility.
CONCLUSIONS: These findings indicate that FGFR2 was associated with breast cancer risk in the Han Chinese population, support the hypothesis that the applicability of a common susceptibility locus must be confirmed among genetically different populations.

Entities:  

Keywords:  FGFR2; Single nucleotide polymorphism (SNP); breast cancer; case-control studies

Year:  2015        PMID: 26175953      PMCID: PMC4497451     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  22 in total

1.  Genetic variants at chromosome 9p21, 10p15 and 10q22 and breast cancer susceptibility in a Chinese population.

Authors:  Jiaping Chen; Yue Jiang; Xiaoan Liu; Zhenzhen Qin; Juncheng Dai; Guangfu Jin; Hongxia Ma; Shui Wang; Xinru Wang; Zhibin Hu; Hongbing Shen
Journal:  Breast Cancer Res Treat       Date:  2011-12-25       Impact factor: 4.872

2.  SNPStats: a web tool for the analysis of association studies.

Authors:  Xavier Solé; Elisabet Guinó; Joan Valls; Raquel Iniesta; Víctor Moreno
Journal:  Bioinformatics       Date:  2006-05-23       Impact factor: 6.937

3.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.

Authors:  David J Hunter; Peter Kraft; Kevin B Jacobs; David G Cox; Meredith Yeager; Susan E Hankinson; Sholom Wacholder; Zhaoming Wang; Robert Welch; Amy Hutchinson; Junwen Wang; Kai Yu; Nilanjan Chatterjee; Nick Orr; Walter C Willett; Graham A Colditz; Regina G Ziegler; Christine D Berg; Saundra S Buys; Catherine A McCarty; Heather Spencer Feigelson; Eugenia E Calle; Michael J Thun; Richard B Hayes; Margaret Tucker; Daniela S Gerhard; Joseph F Fraumeni; Robert N Hoover; Gilles Thomas; Stephen J Chanock
Journal:  Nat Genet       Date:  2007-05-27       Impact factor: 38.330

4.  "Westernizing" women's risks? Breast cancer in lower-income countries.

Authors:  Peggy Porter
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

5.  The relationship between menstrual factors and breast cancer according to estrogen receptor status of tumor: a case-control study in African-American women.

Authors:  Kangmin Zhu; Jessica Beiler; Sandra Hunter; Kathleen Payne-Wilks; Chanel L Roland; Digna S Forbes; Vernon M Chinchilli; Louis J Bernard; Kathryn H Jacobsen; Robert S Levine
Journal:  Ethn Dis       Date:  2002       Impact factor: 1.847

6.  Smoking associated with hormone receptor negative breast cancer.

Authors:  J Manjer; J Malina; G Berglund; L Bondeson; J P Garne; L Janzon
Journal:  Int J Cancer       Date:  2001-02-15       Impact factor: 7.396

7.  Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age.

Authors:  Julie A Britton; Marilie D Gammon; Janet B Schoenberg; Janet L Stanford; Ralph J Coates; Christine A Swanson; Nancy Potischman; Kathleen E Malone; Donna J Brogan; Janet R Daling; Louise A Brinton
Journal:  Am J Epidemiol       Date:  2002-09-15       Impact factor: 4.897

8.  A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

Authors:  Gilles Thomas; Kevin B Jacobs; Peter Kraft; Meredith Yeager; Sholom Wacholder; David G Cox; Susan E Hankinson; Amy Hutchinson; Zhaoming Wang; Kai Yu; Nilanjan Chatterjee; Montserrat Garcia-Closas; Jesus Gonzalez-Bosquet; Ludmila Prokunina-Olsson; Nick Orr; Walter C Willett; Graham A Colditz; Regina G Ziegler; Christine D Berg; Saundra S Buys; Catherine A McCarty; Heather Spencer Feigelson; Eugenia E Calle; Michael J Thun; Ryan Diver; Ross Prentice; Rebecca Jackson; Charles Kooperberg; Rowan Chlebowski; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; Alice Sigurdson; Michele Doody; Parveen Bhatti; Bruce H Alexander; Julie Buring; I-Min Lee; Lars J Vatten; Kristian Hveem; Merethe Kumle; Richard B Hayes; Margaret Tucker; Daniela S Gerhard; Joseph F Fraumeni; Robert N Hoover; Stephen J Chanock; David J Hunter
Journal:  Nat Genet       Date:  2009-03-29       Impact factor: 38.330

9.  Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.

Authors:  Olivia Fletcher; Nichola Johnson; Nick Orr; Fay J Hosking; Lorna J Gibson; Kate Walker; Diana Zelenika; Ivo Gut; Simon Heath; Claire Palles; Ben Coupland; Peter Broderick; Minouk Schoemaker; Michael Jones; Jill Williamson; Sarah Chilcott-Burns; Katarzyna Tomczyk; Gemma Simpson; Kevin B Jacobs; Stephen J Chanock; David J Hunter; Ian P Tomlinson; Anthony Swerdlow; Alan Ashworth; Gillian Ross; Isabel dos Santos Silva; Mark Lathrop; Richard S Houlston; Julian Peto
Journal:  J Natl Cancer Inst       Date:  2011-01-24       Impact factor: 13.506

10.  Genome-wide association study identifies novel breast cancer susceptibility loci.

Authors:  Douglas F Easton; Karen A Pooley; Alison M Dunning; Paul D P Pharoah; Deborah Thompson; Dennis G Ballinger; Jeffery P Struewing; Jonathan Morrison; Helen Field; Robert Luben; Nicholas Wareham; Shahana Ahmed; Catherine S Healey; Richard Bowman; Kerstin B Meyer; Christopher A Haiman; Laurence K Kolonel; Brian E Henderson; Loic Le Marchand; Paul Brennan; Suleeporn Sangrajrang; Valerie Gaborieau; Fabrice Odefrey; Chen-Yang Shen; Pei-Ei Wu; Hui-Chun Wang; Diana Eccles; D Gareth Evans; Julian Peto; Olivia Fletcher; Nichola Johnson; Sheila Seal; Michael R Stratton; Nazneen Rahman; Georgia Chenevix-Trench; Stig E Bojesen; Børge G Nordestgaard; Christen K Axelsson; Montserrat Garcia-Closas; Louise Brinton; Stephen Chanock; Jolanta Lissowska; Beata Peplonska; Heli Nevanlinna; Rainer Fagerholm; Hannaleena Eerola; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; David J Hunter; Susan E Hankinson; David G Cox; Per Hall; Sara Wedren; Jianjun Liu; Yen-Ling Low; Natalia Bogdanova; Peter Schürmann; Thilo Dörk; Rob A E M Tollenaar; Catharina E Jacobi; Peter Devilee; Jan G M Klijn; Alice J Sigurdson; Michele M Doody; Bruce H Alexander; Jinghui Zhang; Angela Cox; Ian W Brock; Gordon MacPherson; Malcolm W R Reed; Fergus J Couch; Ellen L Goode; Janet E Olson; Hanne Meijers-Heijboer; Ans van den Ouweland; André Uitterlinden; Fernando Rivadeneira; Roger L Milne; Gloria Ribas; Anna Gonzalez-Neira; Javier Benitez; John L Hopper; Margaret McCredie; Melissa Southey; Graham G Giles; Chris Schroen; Christina Justenhoven; Hiltrud Brauch; Ute Hamann; Yon-Dschun Ko; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Jaana Hartikainen; Nicholas E Day; David R Cox; Bruce A J Ponder
Journal:  Nature       Date:  2007-06-28       Impact factor: 49.962

View more
  21 in total

1.  Correlations between CYP3A4 polymorphism and susceptibility to breast cancer in Chinese Han population.

Authors:  Xu Liu; Xi Huang; Shanshan Zhang; Fanglin Niu; Yongri Ouyang; Zhexing Shou; Jikui Liu
Journal:  Int J Clin Oncol       Date:  2018-09-14       Impact factor: 3.402

2.  Impact of genetic variants in IL-2RA and IL-2RB on breast cancer risk in Chinese Han women.

Authors:  Lingge He; Wenjie Zhang; Shuangyu Yang; Wenting Meng; Xia Dou; Jianfeng Liu; Yuanwei Liu; Haiyue Li; Tianbo Jin
Journal:  Biochem Genet       Date:  2021-01-28       Impact factor: 1.890

3.  Genetic variants in CYP11B1 influence the susceptibility to coronary heart disease.

Authors:  Xiaoli Huang; Yimin Cheng; Na Wang
Journal:  BMC Med Genomics       Date:  2022-07-13       Impact factor: 3.622

4.  CASC15 polymorphisms are correlated with cervical cancer susceptibility in Chinese women.

Authors:  Ziying Gao; Zichao Xiong; Yao Sun; Jiamin Wu; Jianfeng Liu; Yuanwei Liu; Haiyue Li; Bin Li; Tianbo Jin
Journal:  Mol Genet Genomic Med       Date:  2020-04-23       Impact factor: 2.183

5.  MMP8 and MMP9 gene polymorphisms were associated with breast cancer risk in a Chinese Han population.

Authors:  Kai Wang; Yi Zhou; Gang Li; Xinli Wen; Yuan Kou; Jiao Yu; Haifeng He; Qian Zhao; Feng Xue; Jin Wang; Xinhan Zhao
Journal:  Sci Rep       Date:  2018-09-07       Impact factor: 4.379

Review 6.  Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer.

Authors:  Haipeng Lei; Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2017-09-05       Impact factor: 6.580

7.  Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis.

Authors:  Yafei Zhang; Xianling Zeng; Pengdi Liu; Ruofeng Hong; Hongwei Lu; Hong Ji; Le Lu; Yiming Li
Journal:  Oncotarget       Date:  2017-01-10

8.  Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: A meta-analysis.

Authors:  Yafei Zhang; Hongwei Lu; Hong Ji; Le Lu; Pengdi Liu; Ruofeng Hong; Yiming Li
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

9.  CYP17 polymorphisms are associated with decreased risk of breast cancer in Chinese Han women: a case-control study.

Authors:  Pengtao Yang; Meng Wang; Tian Tian; Yanjing Feng; Yi Zheng; Tielin Yang; Hongtao Li; Shuai Lin; Peng Xu; Yujiao Deng; Qian Hao; Na Li; Feng Guan; Zhijun Dai
Journal:  Cancer Manag Res       Date:  2018-07-03       Impact factor: 3.989

10.  FGFR2 gene polymorphism rs2981582 is associated with non-functioning pituitary adenomas in Chinese Han population: a case-control study.

Authors:  Bin Zhu; Juan Wang; Lingling Qin; Lei Wang; Yanfei Zheng; Lei Zhang; Wei Wang
Journal:  Biosci Rep       Date:  2018-11-09       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.